基于人工智能的多式模式模型,用于识别性结肠炎与同时发生的细胞巨乳病毒结肠炎
Haozheng Liang1, Yuxuan Tian2, Gechong Ruan1
1Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Therapeutic advances in gastroenterology
|August 18, 2025
概括
人工智能模型可以帮助检测性结肠炎 (UC) 患者的细胞巨血病毒 (CMV) 大肠炎. 这种多模式的方法可以改善早期诊断,将CMV感染与UC爆发区分开来,从而改善患者的治疗结果.
科学领域:
- 胃肠病学 胃肠病学
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- 在UC患者中,免疫抑制增加了细胞巨型病毒 (CMV) 感染的风险.
- CMV大肠炎会使UC复杂化,导致类固醇耐药性和死亡率增加.
研究的目的:
- 开发基于人工智能的多式模式,用于早期识别患有CMV结肠炎的UC.
- 使用临床和内镜数据,区分CMV大肠炎与UC恶化.
主要方法:
- 对174名UC患者 (87人患有CMV结肠炎) 的回顾性研究,使用3345张结肠镜图像.
- 开发了一种综合临床生物标志物和内镜图像的多式动态亲缘转换 (DAFT) 模型.
- 将DAFT模型性能与ResNet和SeNet进行比较,使用精度,灵敏度和特异性.
主要成果:
- 与其他模型相比,多式DAFT模型实现了更高的精度 (0.91),灵敏度 (0.87),和特异性 (0.93).
- 在患有CMV结肠炎的UC患者中观察到明显的临床特征.
- 该模型在区分UC和CMV结肠炎方面表现出卓越的性能.
结论:
- 人工智能为早期识别带有CMV结肠炎的UC提供了一个有前途的工具.
- 多式联络模式有助于临床医生准确及时诊断.
- 整合临床和内镜数据可以提高复杂的UC病例的诊断能力.
相关概念视频
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
142
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
142
Inflammatory Bowel Disease I: Ulcerative Colitis
321
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
321
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
200
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
200
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
245
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
245
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236


